10 Data Points Revealing the Widening DSO Performance Gap in 2026

Bypaulgruensfelder
BECKER’S DENTAL REVIEW May 13, 2026
Read Full Article →
AI-Generated Summary

Planet DDS’s “2026 Dental Industry Outlook: Deep Dive” analyzed more than 8,500 dental practices and found a deepening divide: one-third grew by more than 10% last year, while nearly 14% declined by more than 10%. The report identifies operational consistency as the primary differentiator — consistent practices produce 28% more daily revenue than volatile ones. DSOs adding at least 75 new patients per month grow at 9% on average, while networks of 26–50 locations show only 2.8% growth as scaling complexity increases. The biggest hidden lever: closing the average billing execution gap in a $10M DSO adds approximately $890,000 in annual EBITDA without touching the top line. Chair utilization and case completion discipline drive more EBITDA than simply adding locations.

Why It Matters

For PE-backed operators and DSO executives, this data reframes the growth conversation: operational consistency and efficiency now drive EBITDA more than location count or production volume. Knowing your benchmark position — patient acquisition rate, case completion, chair utilization — is table stakes for informed capital deployment decisions in 2026.

dso performance dental practice benchmarks operational efficiency ebitda improvement planet dds mso-dso growth case completion rate

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

What separates high-growth DSOs from declining ones in 2026?

Operational consistency is the primary differentiator, according to Planet DDS’s analysis of more than 8,500 dental practices. Consistent practices generate 28% more daily revenue than volatile ones — a gap driven by production predictability, patient retention, and standardized workflows rather than location count or market conditions.

What new patient acquisition rate is associated with strong DSO growth?

DSOs adding at least 75 new patients per month per location grow at 9% on average. This benchmark establishes a clear acquisition floor for growth-oriented operators — below it, organic growth stalls and expansion economics weaken. For PE-backed platforms, tracking new patient rate per location is a leading indicator of portfolio-level performance.

Why do mid-size DSO networks of 26–50 locations show weaker growth than smaller or larger groups?

Planet DDS data shows 26–50 location networks average only 2.8% growth — reflecting the coordination complexity that emerges at scale before centralized systems and standardized playbooks are fully operational. This mid-size squeeze signals that operational infrastructure investment must precede expansion into this range.

Similar Posts

  • Four Forces Disrupting DSO Growth in 2026: PE, Integration, AI, and Diagnostics

    Bypaulgruensfelder

    Four major forces are reshaping DSO growth in 2026: private equity resurging in oral surgery (up 9.1% in PE deals), medical-dental integration expanding through health system partnerships, AI adoption at scale across patient communication and operations, and salivary diagnostics emerging as a clinical frontier. For DSO growth teams and PE investors, this signals where capital and clinical energy are concentrating — and what capabilities will separate market leaders from laggards through 2027.

  • The Attribution Problem Your Board Doesn’t Understand

    Bypaulgruensfelder

    Healthcare marketing attribution is genuinely hard for multi-site groups because patient journeys are long, largely offline, and privacy-constrained—and a budget you can’t defend is a budget that gets cut. Strategy Collective’s Matt Lee argues perfect attribution doesn’t exist, but ‘good enough’ attribution is achievable through four moves: call tracking, redesigned patient intake questions, a blended market-level report, and separating brand demand from generated demand. The bigger fix is reframing the board conversation itself. Instead of asking ‘is marketing working?’, leaders should ask ‘how do we make Market B look like Market A?’—shifting from an unwinnable ROI-proof debate to a comparative, market-level view that drives real reallocation decisions.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • PE’s Quieter Playbook: Joint Ventures With Nonprofit Health Systems

    Bypaulgruensfelder

    Private equity firms are increasingly expanding in healthcare through joint ventures with nonprofit health systems rather than outright buyouts, according to a new report from the Private Equity Stakeholder Project. The report finds 21.4% of private equity-owned hospitals are held through joint venture arrangements with nonprofit systems, and the structure now spans hospitals, inpatient rehab, hospice, home health, behavioral health, ambulatory surgery centers and urgent care — likely an undercount, since the tally covers only publicly identifiable arrangements. Case studies include ventures involving Lifepoint Health, Compassus, Ardent Health Services and Ascension. PESP argues these JVs have drawn far less scrutiny than traditional PE buyouts even as they become more common, prompting calls for greater oversight.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Bypaulgruensfelder

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.